Collegium Pharmaceutical, Inc. COLL Intangible Amortization
Intangible Amortization at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.
The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Collegium Pharmaceutical, Inc.'s intangible amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Collegium Pharmaceutical, Inc.'s intangible amortization?
- Collegium Pharmaceutical, Inc. (COLL) reported intangible amortization of $55.47M in Q1 2026.
- How has Collegium Pharmaceutical, Inc.'s intangible amortization changed year-over-year?
- Collegium Pharmaceutical, Inc.'s intangible amortization decreased by 0.0% year-over-year, from $55.47M to $55.47M.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s intangible amortization?
- Over 2 years (2021 to 2024), Collegium Pharmaceutical, Inc.'s intangible amortization has grown at a 56.9% compound annual growth rate (CAGR), from $67.18M to $165.3M.
- What does intangible amortization mean?
- Non-cash amortization of intangible assets (patents, customer relationships, technology) acquired through M&A or purchases.